AAAAAA
Results:
1-9
|
Results: 9
Authors:
Visani, G
Milligan, D
Leoni, F
Chang, J
Kelsey, S
Marcus, R
Powles, R
Schey, S
Covelli, A
Isidori, A
Litchman, M
Piccaluga, PP
Mayer, H
Malagola, M
Pfister, C
Citation: G. Visani et al., Combined action of PSC 833 (Valspodar), a novel MDR reversing agent, with mitoxantrone, etoposide and cytarabine in poor-prognosis acute myeloid leukemia, LEUKEMIA, 15(5), 2001, pp. 764-771
Authors:
Boldogh, I
Milligan, D
Lee, MS
Bassett, H
Lloyd, RS
McCullough, AK
Citation: I. Boldogh et al., hMYH cell cycle-dependent expression, subcellular localization and association with replication foci: evidence suggesting replication-coupled repair of adenine : 8-oxoguanine mispairs, NUCL ACID R, 29(13), 2001, pp. 2802-2809
Authors:
Tin, W
Milligan, D
Pennefather, P
Citation: W. Tin et al., Oxygen saturation and retinopathy of prematurity - Authors' response, ARCH DIS CH, 85(1), 2001, pp. F75-F75
Authors:
Linch, DC
Smith, P
Hancock, BW
Hoskin, PJ
Cunningham, DC
Newland, AC
Milligan, D
Stevenson, PA
Wood, JK
Maclennan, KA
Hudson, BV
Hudson, GV
Gregory, WM
Citation: Dc. Linch et al., A randomised British National Lymphoma Investigation trial of CHOP vs. a weekly multi-agent regimen (PACEBOM) in patients with histologically aggressive non-Hodgkin's lymphoma, ANN ONCOL, 11, 2000, pp. 87-90
Authors:
McAllister, TA
Gibb, DJ
Kemp, RA
Huisma, C
Olson, ME
Milligan, D
Schwartzkopf-Genswein, KS
Citation: Ta. Mcallister et al., Electronic identification: Applications in beef production and research, CAN J ANIM, 80(3), 2000, pp. 381-392
Authors:
Nitta, AT
Milligan, D
Citation: At. Nitta et D. Milligan, Management of four pregnant women with multidrug-resistant tuberculosis, CLIN INF D, 28(6), 1999, pp. 1298-1304
Authors:
Jensen, DO
Okine, E
Goonewardene, LA
Erichsen-Arychuk, C
Milligan, D
Citation: Do. Jensen et al., Growth response of pastured Simmental calves to a high by-pass protein creep supplement, CAN J ANIM, 79(4), 1999, pp. 557-560
Authors:
Harrison, CN
Gregory, W
Hudson, GV
Devereux, S
Goldstone, AH
Hancock, B
Winfield, D
MacMillan, AK
Hoskin, P
Newland, AC
Milligan, D
Linch, DC
Citation: Cn. Harrison et al., High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML, BR J CANC, 81(3), 1999, pp. 476-483
Authors:
Pasquali, S
Maqueo, JD
Vela, J
Kyle, RA
Leong, T
Fritz, E
Suciu, S
Palva, IP
Oivanen, T
Corrado, C
Lastiri, FJ
Peest, D
Kildahl-Andersen, O
Maniatis, A
Alison, R
Clarke, M
Evans, V
Gray, R
Greaves, E
Hall, E
Hicks, C
James, S
Peto, R
Richards, S
Sinclair, D
Tooth, A
Wheatley, K
Avvisati, G
Boccadoro, M
Bugliosi, R
Mandelli, F
Petrucci, MT
Pileri, A
Tribalto, M
Alexanian, R
Delasalle, KB
Child, J
Dunn, J
MacLennan, I
Milligan, D
Mellstedt, H
Osterborg, A
Hjorth, M
Holmberg, E
Rodjer, S
Westin, J
Kamiya, O
Shimizu, K
Bergsagel, DE
Shustik, C
Hippe, E
Kjaersgaard, E
Turesson, I
Westin, J
Riccardi, A
Ucci, G
Blade, J
Fontanillas, M
De Rosa, L
Montuoro, A
Bartolucci, AA
Omura, GA
Stagg, M
Salmon, S
Tangen, C
Jacobs, P
Wood, L
Levy, LM
Citation: S. Pasquali et al., Combination chemotherapy versus melphalan plus prednisone as treatment formultiple myeloma: An overview of 6,633 patients from 27 randomized trials, J CL ONCOL, 16(12), 1998, pp. 3832-3842
Risultati:
1-9
|